Hikma Pharmaceutical reported $2.14B in Equity Capital and Reserves for its second fiscal semester of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Equity Capital And Reserves Change
Artemis Alpha ATS:LN GBP 124.1M 35.06M
AstraZeneca AZN:LN USD 37.04B 1.9B
Bayer BAYN:GR EUR 38.77B 2.5B
Fresenius FRE:GR EUR 20.42B 967M
Galapagos GLPG:NA EUR 2.53B 164.32M
Genmab GEN:DC DKK 27.44B 784M
GlaxoSmithKline GSK:LN GBP 10.6B 1.45B
Hikma Pharmaceutical HIK:LN USD 2.14B 41M
Lonza Group LONN:SW CHF 10.6B 586M
Merck MRK:GR EUR 25.93B 2.33B
Orion ORNBV:FH EUR 908.1M 63.7M
Recordati REC:IM EUR 1.61B 116.58M
Roche Holding ROG:VX 27.99B 2.8B